Capula Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$443K Buy
1,500
+100
+7% +$29.7K ﹤0.01% 544
2025
Q4
$382K Buy
1,400
+300
+27% +$81.5K ﹤0.01% 438
2025
Q3
$297K Buy
1,100
+400
+57% +$109K ﹤0.01% 531
2025
Q2
$193K Hold
700
﹤0.01% 380
2025
Q1
$186K Buy
+700
New +$173K ﹤0.01% 535
2021
Q4
Sell
-2,900
Closed -$561K 302
2021
Q3
$561K Hold
2,900
0.01% 588
2021
Q2
$617K Sell
2,900
-20,300
-88% -$4.29M 0.01% 422
2021
Q1
$4.74M Sell
23,200
-7,000
-23% -$1.38M 0.09% 210
2020
Q4
$5.5M Buy
+30,200
New +$5.14M 0.27% 85
2020
Q3
Sell
-4,700
Closed -$764K 169
2020
Q2
$764K Buy
+4,700
New +$842K 0.03% 264
2019
Q4
Sell
-11,500
Closed -$2.43M 385
2019
Q3
$2.43M Buy
+11,500
New +$2.4M 0.05% 218

Other funds holding CME

Capula Management's CME Position: Q1 2026 in Review

Capula Management sold out of CME Group (CME) in Q1 2026, closing a stake of 35 shares — an estimated $10.4K sold.

Capula Management first reported a position in CME in Q2 2020 and held it in 7 quarters. The position peaked at $425K in Q3 2021. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Capula Management reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
  • Capula Management sold 35 CME Group shares in Q1 2026, an estimated $10.4K.
  • Capula Management first reported a position in CME Group in Q2 2020 and held it in 7 quarters.
  • Capula Management's CME Group position peaked at $425K in Q3 2021.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.